Dynactin is a dynein-regulating protein that increases the processivity of 20 dynein movement on microtubules. Recent studies have shown that a tripartite complex 21 of dynein-dynactin-Bicaudal D2 is essential for highly processive movement. To 22 elucidate the regulation of dynein motility by dynactin, we focused on two isoforms (A 23 and B) of dynactin 1 (DCTN1), the largest subunit of dynactin that contains both 24 microtubule-and dynein-binding domains. The only difference between the primary 25 structures of the two isoforms is that DCTN1B lacks the K-rich domain, a cluster of 26 basic residues. We measured dynein motility by single molecule observation of 27 recombinant dynein and dynactin. Whereas the tripartite complex containing DCTN1A 28 exhibited highly processive movement, the complex containing DCTN1B dissociated 29 from microtubules with no apparent processive movement. This inhibitory effect of 30 DCTN1B was caused by reductions of the microtubule-binding affinities of both dynein 31 and dynactin, which is attributed to the coiled-coil 1 domain of DCTN1. In DCTN1A, the 32 K-rich domain antagonized these inhibitory effects. Therefore, dynactin has two 33 antagonistic domains and promotes or suppresses dynein motility to accomplish correct 34 localization and functions of dynein within a cell. 35 36 Previous studies have indicated that dynactin enhances microtubule binding of 50 dynein and induces processive movement of dynein using beads coated with multiple 51 dynein molecules [17,18]. More recently, it has been reported that the DD complex itself 52 does not exhibit unidirectional and highly processive movements. However, the dynein-53 dynactin-Bicaudal D2 (BICD2) (DDB) complex has exhibited unidirectional and highly 54 4 processive movements in single molecule observations [19,20]. 55
Introduction 37
Dynactin is a very large multi-subunit complex that links dynein with its cargo 38 and is known as a cytoplasmic dynein modulator by binding dynein to specific vesicles 39 or organelles [1] [2] [3] . Cytoplasmic dynein is a minus end-directed multi-subunit 40 microtubule motor protein [4] . Dynactin is involved in many cellular functions, 41 including vesicle transport [2, 5] , organelle positioning [6, 7] , spindle assembly [8] and 42 microtubule plus end localization [9] [10] [11] with dynein. Dynactin abnormalities cause 43 several diseases, including Perry syndrome [12, 13] and amyotrophic lateral sclerosis 44 [14, 15] . Dynein-dynactin (DD) complexes are distributed broadly range in cells and 45 their spatial distribution changes throughout the cell cycle [16] . Correct localization of 46 the DD complex is important for maintenance of cellular functions. However, the 47 regulatory mechanism of the DD complex in determining its cellular distribution has 48 been poorly understood. 49 5 isoform induces unidirectional movement, whereas the 1B isoform reduces the 73 microtubule-binding affinity to inhibit unidirectional movement. By comparing the 74 properties of the two isoforms and several mutants, we show that both CapGly and 75 K-rich domains are essential for microtubule binding of dynein to promote 76 unidirectional movement. Furthermore, we found that the CC1 domain is responsible 77 for reductions of the microtubule-binding affinities of both dynein and dynactin and 78 that the K-rich domain antagonizes these effects. We conclude that DCTN1 has two 79 antagonistic regulatory domains that interact intramolecularly with each other and 80 then exerts opposing effects on dynein motility. 81 82 Materials and Methods 83 Construction of expression vectors 84 cDNAs encoding DCTN1 isoforms and BICD2 were amplified from HEK293 85 cells by RT-PCR. The PCR primers used for cloning DCTN1 isoforms were as follows: 86 5´-ATGGCACAGAGCAAGAGGCAC-3´ and 5´-TTAGGAGATGAGGCGACTGTG-3´ for DCTN1 87 (NM_004082), and 5´-ATGTCGGCGCCGTCGGAGGAG-3´ and 88 5´-CTACAGGCTCGGTGTGGCTGGCTTGG-3´ for BICD2 (NM_015250). Note that our 89 cloned DCTN1 sample from HEK293 cells was 1B isoform which lacked 21 amino acids 90 6 of the K-rich domain (exon 5-7) as reported by Dixit et al [32] . cDNA for the 1A isoform 91 was constructed by inverse PCR using the following PCR primers: 92 5´-GCCCGAAAGACCACAACTCGGCGACCCAAGCCCACGCGCCCAGCCAGTACT-3´ 93 and 94 5´- For 1BCC1 mutant construction, the CC1 domain-coding region was deleted using the 96 following PCR primers: 5´-CCACCTCCAGAGACCTTTGAC-3´ and 97
5´-TGGGGAAGGAAGCGGGGGGAC-3´. 98
The PCR products were cloned into pcDNA5/FRT/TO (LifeTechnologies), a 99 tetracycline-inducible mammalian expression vector. For protein purification, the 100 streptavidin-binding peptide (SBP)-tag-inserted multifunctional green fluorescent 101 protein (GFP)-tag [33] cultured in 20 150-mm culture dishes, and then collected and rinsed twice with 116 phosphate-buffered saline. Cell lysates were prepared by homogenizing the cells in 117 buffer B (10 mM Pipes-NaOH, pH 7.0, 200 mM NaCl, 10% sucrose, and 1 mM 118 dithiothreitol) containing 0.05% Triton X-100 and complete mini protease inhibitor 119 cocktail (Roche, Basel, Swiss). After centrifugation and filtration, the lysates were 120 applied to a StrepTrap HP column (GE healthcare, Amersham, UK) that had been 121 equilibrated with buffer B. After washing with buffer A (10 mM Pipes-NaOH, pH 7.0, 122 150 mM NaCl, and 1 mM dithiothreitol), bound proteins were eluted with buffer B 123 containing 2.5 mM desthiobiotin. Purified DCTN1 isoforms and mutants were 124 confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 125 (S1 Fig) . 126 8 The CC1 fragment consisted of 214-547 a.a. of p150 Glued . The 1BN-GCN4 127 fragment consisted of 1-193 a.a. of the 1B isoform and the GCN4 sequence [34] to 128 dimerize this fragment. These fragments were fused with GFP and a His-tag at the 129 C-terminus. CC1 and 1BN-GCN4 fragments were expressed in pET and pCold 130 expression systems, respectively. These fragments were then purified using profinity 131 IMAC Ni-charged Resin (Bio-Rad, Hercules, CA). 132
Tubulin was purified from porcin brain as described by Weingarten [35] . 133
Tubulin was incubated for 30 min at 37°C with 1 mM GTP and 5 mM MgSO4 to 134 polymerize. After the incubation, taxol was added to a final concentration of 40 µM. 135 136 Single molecule observation 137 Flow chambers were constructed with silanized glass, which were coated with a 138 5% anti-β tubulin antibody solution and then blocked with 10% Pluronic F-127 and 139 casein. Taxol-stabilized microtubules were introduced into the flow chamber to obtain a 140 constant density of microtubules on the glass surface in each experiment, followed by 141 Alexa 647-labeled dynein and GFP-labeled dynactin in SM buffer (12 mM Pipes-KOH, 142 pH 6.8, 25 mM KAce, 1 mM ATP, 2 mM DTT, 10% saturated casein, and an 143 oxygen-scavenging system). Single molecule observations were performed at 25°C using 144 9 a total internal reflection fluorescence (TIRF) microscope (IX71, Olympus, Tokyo, 145 Japan) equipped with a 100×/1.45 PlanApo objective lens (Olympus). Images were 146 acquired with a back illumination EMCCD camera (iXon, DV887DCS-BV, Andor, UK) at 147 an exposure time of 100 ms. 148
Dynein and dynactin behaviors were analyzed by recording fluorescent spots 149 that were visible along microtubules for more than 1 s. The numbers of dynein and 150 dynactin molecules were counted per microtubule length of 10 µm for 10 s under the 151 condition of 1 nM dynein or dynactin molecules. The attachment rate was the number of 152 newly detected molecules on a microtubule for 10 s. Spots of dynein that moved 153 bidirectionally for more than 400 nm were classified as "diffusive", those that moved 154 bidirectionally for less than 400 nm were classified as "stationary", and those that 155 moved to the minus end by more than 400 nm were classified as "unidirectional". Previous studies have indicated that the DDB complex exhibits highly 171 processive and unidirectional movements [19, 20] . However, the difference in DCTN1 172 isoforms of dynactin remains unknown in the DDB complex. To investigate whether 173 DCTN1 isoforms influence the highly processive movement of DDB complexes, we 174 observed the behavior of DDB complexes with different DCTN1 isoforms (1A and 1B) by 175 TIRF microscopy (Fig 1) . To this end, each DCTN1 isoform was fused with a 176 multifunctional GFP-tag at the N-terminus and expressed in HEK293 cells (Fig 1a) . 177
These DCTN1 isoforms were incorporated into the endogenous dynactin complex and 178 successfully purified by affinity chromatography (S1 Fig) . 179
We observed the behavior of Alexa647-labeled dynein on microtubules (Fig 1b) 180 11 and classified it into three types, i.e., diffusive, stationary and unidirectional movement 181 ( Fig 1c) . The number of dynein molecules exhibiting each type of movement was 182 calculated based on our counting criteria (see Materials and Methods). In the absence of 183 dynactin (dynein + BICD2), the number of dynein molecules on microtubules was 5.6 ± 184 0.8. Dynein was either stationary (55%) or diffusive (45%) and no processive movement 185 was observed (Fig 1b, 1c and S1 Table) . Addition of the 1A isoform (DDB 1A) did not 186 change the number of dynein molecules on microtubules (5.2 ± 1.0). However, a 187 significant fraction of dynein (17%) moved unidirectionally with marked reduction in 188 the diffusive fraction (12%) and an increase in the stationary fraction (71%) compared 189 with the absence of dynactin. The unidirectional movement occurred with a mean 190 velocity of 229.7 ± 182.3 nm/s and a mean run length of 4.2 ± 3.5 m (Fig 1d) . The highly 191 processive movement of the DDB complex with the 1A isoform is consistent with 192 previous reports [19, 20] . In contrast, addition of the 1B isoform (DDB 1B) resulted in a significantly 209 lower number of dynein molecules on microtubules (2.1 ± 0.7, P < 0.01) than without 210 dynactin or with the 1A isoform. Most dynein was stationary (81%) and the remaining 211 fraction was diffusive (19%). No unidirectional movement was observed (Figs 1b and 1c) . 212
These results suggest that the 1A isoform is essential for unidirectional processive 213 movement of the DDB complex. Furthermore, the fact that addition of the 1B isoform 214 reduced the number of dynein molecules on microtubules suggests that the 1B isoform To investigate the effect of DCTN1 isoforms on dynein motility in a more simple 220 system, we observed the behavior of DD complexes on microtubules in the absence of 221 BICD2 (Fig 2a) . The number of dynein molecules on microtubules was 7.1 ± 1.7 222 molecules in the absence of dynactin (Fig 2b) . Seventy-six percent of the observed 223 dynein exhibited diffusive motion and 24% of dynein molecules were stationary (Fig 2b  224 and S1 Table) . The number of dynein molecules on microtubules was slightly decreased 225 in the presence of the 1A isoform (5.6 ± 1.0 dynein molecules, P < 0.01). The fraction of 226 stationary dynein molecules was increased to 59%, and 27% of dynein molecules 227 exhibited diffusive motion. Surprisingly, 14% of dynein molecules exhibited 228 unidirectional processive movement (S1 Movie). The mean velocity and run length of 229 the unidirectional movement were 130.0 ± 79.5 nm/s and 1.6 ± 0.9 m, respectively ( Fig  230   2c ), which were lower than those of the DDB complex (see Fig 1d) . Conversely, in the 231 presence of the 1B isoform, the number of dynein molecules was drastically decreased to 232 0.6 ± 0.5 (Figs 2a and 2b) . Whereas 79% of dynein in the presence of the 1A isoform did 233 not dissociate from microtubules during the observation (30 sec) (Fig 2a) , the duration 234 14 of dynein molecules on microtubules was greatly reduced in the presence of the 1B 235 isoform (τ = 1.2 s) compared with the 1A isoform (Fig 2d) . These findings indicate that 236 the 1A isoform is necessary and sufficient for the unidirectional movement, and that the 237 1B isoform inhibits the microtubule binding ability of dynein. The number of dynein molecules on MTs was the same as that in Fig. 1c The CC1 domain inhibits dynein motility.
254
The above results clearly demonstrated that the 1B isoform inhibits the 255 microtubule-binding ability of dynein in both the DDB complex (Fig 1) and DD complex 256 ( Fig 2) . We hypothesized that the binding of dynactin with the 1B isoform to dynein 257 affects its microtubule-binding ability. It is known that the CC1 domain of DCTN1 binds 258 to the dynein intermediate chain [24] , and the Arp1-rod interacts with the dynein tail 259 [36] . Therefore, we investigated the effect of the CC1 domain on the microtubule 260 binding ability of dynein. 261
We constructed the CC1 fragment and the 1B isoform lacking the CC1 domain 262 (1BCC1) (Fig 3a) and initially examined the binding ability of the CC1 domain to 263 dynein by pull-down assays with the purified proteins (Figs 3b and 3c ). The 1B isoform 264 bound to dynein in a simple 1:1 binding ratio with a dissociation constant (kd) of 2.3 nM. 265
The engineered CC1 fragment also exhibited a similar binding ability with a 266 dissociation constant (kd) of 2.0 nM. Conversely, the 1B isoform lacking the CC1 domain 267 (1BCC1) did not specifically bind to dynein. These results indicate that the CC1 268 domain is the primary dynein-binding site of dynactin. We next examined the effect of the CC1 fragment and 1BCC1 mutant on the 284 microtubule-binding ability of dynein (Fig 3d) . The CC1 fragment greatly reduced the 285 number of dynein molecules (0.3 ± 0.4, Fig 3e) to a level similar to that with the 1B 286 isoform (0.6 ± 0.5, Fig 2b) . In contrast, the number of dynein molecules in the presence 287 of the 1BCC1 mutant did not significantly differ (5.9 ± 1.6, Fig 3e) compared with 288 dynein alone (7.1 ± 1.7, Fig 2b) . These results demonstrate that the CC1 domain binds 289 to dynein and inhibits the microtubule-binding ability of dynein. 290 291 Microtubule-binding affinities of DCTN1 isoforms 292
The fact that the CC1 domain binds to dynein and inhibits its microtubule 293 binding in the 1B isoform raises an important issue: why the 1A isoform does not inhibit 294 the microtubule binding of dynein and enables unidirectional processive movement. 295
Dynactin itself interacts with microtubules via the N-terminal region of DCTN1 that 296 contains a CapGly domain [23, 28] . Because the K-rich domain is reported to increase 297 the microtubule-binding ability of the CapGly domain, we hypothesized that the 298 microtubule-binding ability of each DCTN1 isoform might be different. To estimate the 299 microtubule-binding abilities of DCTN1 isoforms, we observed the behavior of dynactin 300 on microtubules by TIRF microscopy. The 1A isoform was frequently observed on 301 microtubules (Fig 4b) and the number of dynactin molecules on microtubules was 6.6 ± 302 1.3 (Fig 4c) . In contrast, the 1B isoform exhibited a 10-fold reduction in the number of 303 dynactin molecules on microtubules (0.6 ± 0.6). 304
The 1A isoform exhibited highly diffusive movements with a diffusion 305 coefficient of 46.9 × 10 2 nm 2 /s (Fig 4d and S2 Fig) and interacted with microtubules for 306 18 an average of 2.0 s (Fig 4e) . Conversely, the 1B isoform moved much less diffusively with 307 a diffusion coefficient of 2.0 × 10 2 nm 2 /s (Fig 4d and S2 Fig) and the dwell time on 308 microtubules was 0.8 s (Fig 4e) . The attachment rates of 1A and 1B isoforms were 5.5 ± 309 0.6 and 1.2 ± 0.4, respectively (Fig 4f) . Because the dissociation constant is proportional 310 to the product of the attachment rate and duration, the dissociation constants of 1A and 311 1B isoforms were 0.1 × 10 2 m nM and 1.0 × 10 2 m nM, respectively. Thus, the 312 microtubule-binding affinity of the 1A isoform was 10-fold more than that of the 1B 313 isoform. The observed number of molecules on microtubules (see Fig 4c) was consistent 314 with the microtubule-binding affinity, indicating that the number of molecules based on 315 our criteria is a good measure of the microtubule-binding affinity. 316
These results suggest that the 1B isoform has much lower microtubule-binding 317 ability than the 1A isoform. Thus, the K-rich domain represses the inhibitory effect of 318 the CC1 domain on the microtubule-binding ability of the 1A isoform. To examine the effect of the CC1 domain on the microtubule-binding ability of 336 dynactin, we deleted the CC1 domain from the 1B isoform (1BCC1). Interestingly, the 337 1BCC1 mutant interacted with microtubules (8.0 ± 1.8), which was comparable to the 338 1A isoform (6.6 ± 1.3). Similarly, the 1BN-GCN4 fragment, which was the dimerized 339 N-terminal fragment of the 1B isoform induced by the GCN4 sequence, interacted with 340 microtubules at a similar level (9.6 ± 1.7, Fig 4c) . The CC1 fragment itself did not 341 interact with microtubules (Fig 4c) . These results suggest that the N-terminal region is 342 20 a unique site in the dynactin complex to interact with microtubules. The 343 microtubule-binding ability of the CapGly domain is reduced by the CC1 domain and 344 the K-rich domain antagonizes the inhibitory effect of the CC1 domain. 345 346 Discussion 347
In this study, we found that dynactin has two agonistic regulatory domains 348 (CC1 and K-rich domains) and exerts opposing effects on dynein motility depending on 349 the DCTN1 isoform. The function of dynactin to increase dynein processivity, which has 350 already been shown in previous reports [19, 20] , is considered to be attributed to the 1A 351 isoform. Other than neurons, most tissues express more of the 1B isoform than the 1A 352 isoform [27, 31] . It appears that both 1A and 1B isoforms of DCTN1 coexisted in the 353 previous reports [37, 38] , and the observed highly processive movement was achieved by 354 the fraction with the 1A isoform. While the effect of the 1A isoform has been observed in 355 previous studies, the properties of the 1B isoform were not revealed. In this study, we 356 used recombinant DCTN1 isoforms and each isoform was investigated separately. 357
Recombinant DCTN1 was incorporated into the dynactin complex and affinity purified 358 using the SBP-tag in the fused multifunctional GFP [33] (S1 Fig) . This purification 359 method made it possible to isolate the dynactin complex with one DCTN1 isoform or 360 21 mutant to compare the functions of the isoforms in dynein motility. Moreover, we 361 evaluated the microtubule-binding ability of dynein by quantitative single molecule 362 analysis. As a result, we were able to determine the unbinding property of DD 363 complexes. So far, the unbinding property has not been assessed by single molecule 364 analysis because it is an invisible phenomenon. Our strategies revealed new functions 365 of several domains within DCTN1. 366
In the presence of the 1A isoform, we detected a decrease in the fraction of 367 diffusive molecules of the DD complex, but an increase in that of stationary molecules 368 compared with dynein alone (Fig 2b) . The increase in stationary dynein might be due to 369 the increase in microtubule-binding affinity, because the number of microtubule-binding 370 sites in a DD complex is twice that in dynein alone. Alternatively, while diffusive motion 371 does not appear to be involved in the unique binding of dynein to microtubules, dynactin 372 might increase the unique binding of dynein, leading to the increase in stationary 373 fractions. The DD complex with the 1A isoform generated unidirectional movement in a 374 manner similar to that of multimolecular dyneins [39] . Because the DDB complex 375 showed higher velocity and processivity (Fig 1d) than the DD complex (Fig 2c) , BICD2 376 appears to regulate the complex to achieve a stable state that is favorable for the 377 unidirectional movement and then increases processivity. 378 22 Conversely, the 1B isoform reduced the microtubule-binding affinity of dynein 379 in both DDB and DD complexes (Figs 1c and 2b) . Thus, the 1B isoform has an inhibitory 380 effect on dynein motility. Because the only difference between the two isoforms is that 381 the 1B isoform lacks the K-rich domain, this domain is important to support the 382 microtubule-binding ability of the CapGly domain. Furthermore, the lack of the K-rich 383 domain caused dissociation of the DDB complex (DDB 1B) (Fig 1c) and DD complex (Fig  384   2b ). Therefore, the K-rich domain represses the dissociation of DDB and DD complexes 385 by the 1B isoform (Fig 5, right, regions. Therefore, we focused on the CC1 domain that contains the dynein-binding site. 395
The CC1 fragment, CC1-GFP, reduced the microtubule-binding affinity of dynein ( Fig  396   23 3e), suggesting that the CC1 domain is a regulatory unit to inhibit dynein motility (Fig 397 5, right, red dashed line) . This result is supported by a previous study using dynein 398 molecule-coated beads [40] . Based on previous studies, the CC1 fragment is known to be 399 a dynein inhibitor because the addition of excess CC1 fragments disrupts the DD 400 complex by competitive inhibition with endogenous dynactin in cells [41, 42] . Our 401 finding of the inhibitory effect of CC1 on dynein motility in vitro suggests that the 402 inhibition of dynein motility in a cell is not only caused by disruption of DD complex but 403 also by the direct inhibitory effect of CC1. 404
The inhibitory mechanism of the microtubule-binding ability of dynein by the 405 CC1 domain is unknown. The CC1 domain is reported to contain the primary 406 dynein-binding site that binds to the dynein intermediate chain [24, 43, 44] . Because the 407 dynein heavy chain is involved in microtubule binding [45] , it is plausible that the CC1 408 domain also interacts with the heavy chain. The CC1 domain might have a secondary 409 binding site for dynein, which may influence the microtubule-binding site of dynein, 410 such as the stalk [46] or strut [47] . 411
We further found that the CC1 domain affected the microtubule-binding ability 412 of dynactin itself. The number of 1BCC1 mutant molecules on microtubules (8.0) was 413 higher than that of the 1B isoform (0.6) (Fig 4c) , and the microtubule-binding affinity of 414 24 the 1BCC1 mutant was similar to that of the 1BN-GCN4 fragment as the dimerized 415
CapGly fragment (Fig 4c) . Thus, the CC1 domain may inhibit the microtubule-binding 416 ability of the CapGly domain (Fig 5, left, red solid line) . The number of 1A isoform 417 molecules on microtubules, in contrast, was 6.6, which was much higher than that of 418 the 1B isoform (0.6) (Fig 4c) . As the 1A isoform has the K-rich domain, the K-rich 419 domain represses the inhibitory effect of the CC1 domain ( Fig 5, left, blue solid line) . 420 Furthermore, the repression by the K-rich domain of the 1A isoform might not be 421 complete, because the binding durations of the 1A isoform (2.0 s) was still lower than 422 that of the CapGly fragment (2.9 s) in a previous study [28] . Thus, DCTN1 has two 423 regulatory domains, K-rich and CC1, which interact intramolecularly with each other 424 and change the microtubule-binding affinity of dynactin. 425
Although the 1A isoform induced unidirectional movement of the DD complex, 426 the number of dynein molecules on microtubules with the 1A isoform was slightly lower 427 than that of dynein alone (Fig 2b) . Moreover, we detected an increase in the fraction of 428 stationary molecules of the DDB complex with the 1B isoform (Fig 1c) . These results 429 suggest that the properties of the two isoforms are not exclusive, and that dynactin 430 possesses opposing properties and the distinctive function of each isoform is constituted 431 by a predominated one of opposing properties of the regulatory domains in DCTN1 (Fig 432 25 5, left) . 433
In a cell, the DD complex localizes at microtubule plus ends [10, 16, 48] 
